BMO Capital Markets reissued their buy rating on shares of Clorox Company (The) (NYSE:CLX) in a research note issued to investors on Thursday morning. They currently have a $150.00 price target on the stock.

CLX has been the topic of a number of other reports. Deutsche Bank AG reissued a hold rating and set a $137.00 price target (up from $126.00) on shares of Clorox Company (The) in a research report on Saturday, July 22nd. Zacks Investment Research cut shares of Clorox Company (The) from a hold rating to a sell rating in a research report on Wednesday. BidaskClub cut shares of Clorox Company (The) from a hold rating to a sell rating in a research report on Wednesday, July 5th. Royal Bank Of Canada reaffirmed a hold rating and issued a $115.00 price objective on shares of Clorox Company (The) in a research report on Friday, June 30th. Finally, Barclays PLC reaffirmed an equal weight rating and issued a $136.00 price objective (down from $140.00) on shares of Clorox Company (The) in a research report on Friday, August 4th. Three equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have assigned a buy rating to the company’s stock. The company currently has an average rating of Hold and a consensus target price of $127.39.

Shares of Clorox Company (NYSE:CLX) opened at 129.14 on Thursday. Clorox Company has a 52 week low of $111.24 and a 52 week high of $141.76. The firm’s 50-day moving average is $134.59 and its 200 day moving average is $134.61. The firm has a market capitalization of $16.67 billion, a P/E ratio of 24.21 and a beta of 0.39.

Clorox Company (The) (NYSE:CLX) last announced its quarterly earnings results on Thursday, August 3rd. The company reported $1.53 earnings per share for the quarter, topping analysts’ consensus estimates of $1.49 by $0.04. The company had revenue of $1.65 billion for the quarter, compared to analysts’ expectations of $1.65 billion. Clorox Company (The) had a net margin of 11.74% and a return on equity of 190.67%. The business’s quarterly revenue was up 2.9% compared to the same quarter last year. During the same period last year, the firm posted $1.30 earnings per share. Equities research analysts forecast that Clorox Company will post $5.66 EPS for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: “Clorox Company (The)’s (CLX) “Buy” Rating Reiterated at BMO Capital Markets” was reported by Watch List News and is the property of of Watch List News. If you are accessing this story on another website, it was illegally copied and republished in violation of US & international copyright & trademark laws. The legal version of this story can be accessed at https://www.watchlistnews.com/clorox-company-thes-clx-buy-rating-reiterated-at-bmo-capital-markets/1617628.html.

The firm also recently declared a quarterly dividend, which will be paid on Monday, November 13th. Shareholders of record on Wednesday, October 25th will be paid a $0.84 dividend. The ex-dividend date is Tuesday, October 24th. This represents a $3.36 annualized dividend and a yield of 2.60%. Clorox Company (The)’s payout ratio is currently 63.04%.

In other Clorox Company (The) news, COO Dawn C. Willoughby sold 2,158 shares of Clorox Company (The) stock in a transaction on Tuesday, August 29th. The shares were sold at an average price of $138.00, for a total value of $297,804.00. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP James E. Foster sold 9,861 shares of Clorox Company (The) stock in a transaction on Wednesday, August 23rd. The shares were sold at an average price of $138.51, for a total transaction of $1,365,847.11. Following the completion of the sale, the executive vice president now owns 22,069 shares in the company, valued at $3,056,777.19. The disclosure for this sale can be found here. Insiders sold a total of 21,242 shares of company stock worth $2,944,449 over the last quarter. Company insiders own 1.00% of the company’s stock.

A number of hedge funds have recently modified their holdings of the business. Vanguard Group Inc. increased its stake in Clorox Company (The) by 2.6% in the 2nd quarter. Vanguard Group Inc. now owns 14,534,634 shares of the company’s stock valued at $1,936,595,000 after buying an additional 369,918 shares during the last quarter. BlackRock Inc. increased its stake in Clorox Company (The) by 1,402.2% in the 1st quarter. BlackRock Inc. now owns 10,390,206 shares of the company’s stock valued at $1,400,912,000 after buying an additional 9,698,542 shares during the last quarter. State Street Corp increased its stake in Clorox Company (The) by 2.2% in the 1st quarter. State Street Corp now owns 7,648,999 shares of the company’s stock valued at $1,031,304,000 after buying an additional 167,689 shares during the last quarter. Wells Fargo & Company MN increased its stake in Clorox Company (The) by 5.3% in the 2nd quarter. Wells Fargo & Company MN now owns 4,412,600 shares of the company’s stock valued at $587,934,000 after buying an additional 221,168 shares during the last quarter. Finally, Valueinvest Asset Management S.A. increased its stake in Clorox Company (The) by 6.9% in the 1st quarter. Valueinvest Asset Management S.A. now owns 1,580,400 shares of the company’s stock valued at $213,085,000 after buying an additional 102,300 shares during the last quarter. Hedge funds and other institutional investors own 71.33% of the company’s stock.

About Clorox Company (The)

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Analyst Recommendations for Clorox Company (The) (NYSE:CLX)

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with Analyst Ratings Network's FREE daily email newsletter.